Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.019x

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (688505) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥43.77 Million ≈ $6.41 Million USD) by net assets (CN¥2.26 Billion ≈ $330.53 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (2006–2025)

Cash flow conversion efficiency of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd from 2006 to 2025. This chart illustrates how Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 688505 live share price for real-time trading data and today's change.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see how much is Shanghai Fudan-Zhangjiang Bio-Pharmaceut worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Cosonic Intelligent Tech Co Ltd SHE:300793	-0.026x
Lotte Reit Co Ltd KO:330590	N/A
Metro Healthcare Indonesia JK:CARE	0.005x
Jiangsu TongLin Electric Co.Ltd. SHE:301168	-0.007x
Sichuan Jiuyuan Yinhai Software Co Ltd SHE:002777	0.139x
Pakuwon Jati Tbk JK:PWON	0.026x
Sichuan Yimikang Environmental Tech Co Ltd SHE:300249	0.053x
Heilongjiang Transport Development Co Ltd SHG:601188	0.024x

Annual Cash Flow Conversion Efficiency for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (2006–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd from 2006 to 2025. Review Shanghai Fudan-Zhangjiang Bio-Pharmaceut (688505) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.12 Billion ≈ $309.74 Million	CN¥141.40 Million ≈ $20.69 Million	0.067x	+1142.58%
2024-12-31	CN¥2.31 Billion ≈ $337.33 Million	CN¥-14.77 Million ≈ $-2.16 Million	-0.006x	-121.28%
2023-12-31	CN¥2.36 Billion ≈ $345.13 Million	CN¥71.02 Million ≈ $10.39 Million	0.030x	-58.95%
2022-12-31	CN¥2.25 Billion ≈ $329.69 Million	CN¥165.27 Million ≈ $24.18 Million	0.073x	-40.27%
2021-12-31	CN¥2.19 Billion ≈ $320.41 Million	CN¥268.90 Million ≈ $39.35 Million	0.123x	+118.28%
2020-12-31	CN¥2.01 Billion ≈ $293.91 Million	CN¥113.00 Million ≈ $16.54 Million	0.056x	-80.50%
2019-12-31	CN¥933.15 Million ≈ $136.55 Million	CN¥269.23 Million ≈ $39.40 Million	0.289x	+64.76%
2018-12-31	CN¥993.28 Million ≈ $145.35 Million	CN¥173.94 Million ≈ $25.45 Million	0.175x	+265.92%
2017-12-31	CN¥892.48 Million ≈ $130.60 Million	CN¥42.71 Million ≈ $6.25 Million	0.048x	-70.28%
2016-12-31	CN¥873.05 Million ≈ $127.76 Million	CN¥140.57 Million ≈ $20.57 Million	0.161x	+28.05%
2015-12-31	CN¥765.84 Million ≈ $112.07 Million	CN¥96.30 Million ≈ $14.09 Million	0.126x	-3.74%
2014-12-31	CN¥676.42 Million ≈ $98.98 Million	CN¥88.36 Million ≈ $12.93 Million	0.131x	-17.35%
2013-12-31	CN¥565.92 Million ≈ $82.81 Million	CN¥89.44 Million ≈ $13.09 Million	0.158x	-62.69%
2012-12-31	CN¥260.11 Million ≈ $38.06 Million	CN¥110.19 Million ≈ $16.12 Million	0.424x	+71.76%
2011-12-31	CN¥201.07 Million ≈ $29.42 Million	CN¥49.59 Million ≈ $7.26 Million	0.247x	+685.36%
2010-12-31	CN¥168.71 Million ≈ $24.69 Million	CN¥-7.11 Million ≈ $-1.04 Million	-0.042x	-191.84%
2009-12-31	CN¥168.37 Million ≈ $24.64 Million	CN¥7.72 Million ≈ $1.13 Million	0.046x	+121.91%
2008-12-31	CN¥75.88 Million ≈ $11.10 Million	CN¥-15.89 Million ≈ $-2.33 Million	-0.209x	+13.44%
2007-12-31	CN¥71.04 Million ≈ $10.40 Million	CN¥-17.18 Million ≈ $-2.51 Million	-0.242x	-14.96%
2006-12-31	CN¥101.70 Million ≈ $14.88 Million	CN¥-21.40 Million ≈ $-3.13 Million	-0.210x	--

About Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd

SHG:688505 China Drug Manufacturers - Specialty & Generic

Market Cap

$728.33 Million

CN¥4.98 Billion CNY

Market Cap Rank

#9999 Global

#2607 in China

Share Price

CN¥7.08

Change (1 day)

-2.48%

52-Week Range

CN¥6.68 - CN¥9.14

All Time High

CN¥39.80